Failure to confirm evidence for existence of two populations with duodenal ulcer A previous study on 339 patients attending a gastrointestinal unit suggested that patients with duodenal ulcer could be divided into two types.1 2 The distinction was based on maximal acid secretion and apparent differences in the prevalence of several clinical features, particularly family history, bleeding and perforation, and ABO blood grouping. In a further series of two groups of 100 patients referred consecutively to the same unit, however, no such distinction could be made. The results of this further study are presented here.
Methods and results
The two groups of patients, who were investigated between October 1974 and October 1975, were proved radiologically and endoscopically to have duodenal ulcer. In every case the maximal acid output (MAO) was measured in response to 6 ,ag pentagastrin/kg total body weight (TBW). MAO was expressed as the amount of HC1 excreted/kg TBW, thereby reducing the difference between the sexes.3 Mean MAO levels were used and tests of significance based on a comparison of these. Such tests have a better chance of detecting significance than tests based on contingency tables. The results in each of the two groups are given separately.
The mean MAO levels (+SD) in the two groups were 0 48+0 19 and 0 49±+020 mmol HCl/kg TBW respectively (see 
Comment
These results fail to support the existence of two types of patient with duodenal ulcer, for the MAO appears to be unaffected by any variable. Although expressing the absolute MAO in terms of body weight reduces the difference between the sexes, it does not abolish it.3 Likewise, the possibility of certain clinical features being associated with MAO was not confirmed. Though such discrepant observations in the same unit may seem surprising, experience shows that the usually acceptable level of significance of 1 in 20 (P < 0 05) is often found in this field when a true association is shown later not to exist. P values of < 0 01 are also often found and shown later to have been due to chance, almost always because of poor control data.
In practice a probability of less than 1 in 1000 (P < 0 001) should be obtained before a difference in ABO blood group frequency from controls is regarded as significant.4 Patients are now referred earlier in the course of the disease and thus the memory of the date of onset is more accurate. Furthermore, during the period covered by this and the previous study there were appreciable social changes in Britain, with an increase in the standards of living and nutrition of the social classes to which most of our patients belonged. Hence, duodenal ulcer altered from being a disease of the well-to-do to that of the "poorer" classes.5 Such changes may reflect movement up the social (housing and nutrition) scale of people in occupations that have traditionally been recorded as in classes III-V in the Registrar General's returns.
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Consumption coagulopathy after intra-amniotic urea
Haemorrhage is a well-documented complication of intra-amniotic hypertonic saline and glucose but frank bleeding has not previously been reported after intra-amniotic urea. Several reports have suggested that urea is safer to use than saline and glucose,1-3 though McKenzie4 showed subclinical changes in many patients treated with urea. No such changes have been observed with oxytocin alone. We report a case of proved consumption coagulopathy resulting from the use of intrauterine hypertonic urea and intravenous oxytocin to induce a mid-trimester abortion.
Case report
A 24-year-old French primipara was admitted to a private nursing home at 16 weeks' gestation for termination. Amniocentesis was reported as uneventful, a free flow of liquor being obtained. A dose of 80 g urea in 200 ml normal saline was injected slowly. At the same time 50 U oxytocin in 1000 ml 5 %,O dextrose was given intravenously over 12 hours. Although contractions were noted, abortion had not occurred 28 hours later. The cervix was dilated, however, and curettage was performed without further dilatation under general anaesthesia. The fetus and placenta were removed uneventfully. On her return to the ward persistent vaginal bleeding was noted, and a second and later a third examination under anaesthesia was performed and the uterus packed. No residual products of conception or cervical or uterine injury were found. By the third examination the blood was noted to be failing to clot. Fibrinogen titre was 1/4 (control 1/32). She was transfused with 3 U triple-strength plasma, 1 U (about 2-5 g) fibrinogen concentrate, and 2 units whole blood and transferred to hospital.
On admission she was found to be shocked. No fresh bleeding was noted. The uterus was well contracted but enlarged to 18 weeks' gestation. There was a purpuric area around the site of the amniocentesis. Central venous pressure was monitored and 2 U whole blood and 2 U fibrinogen were given. Results of haematological investiagtions were: haemoglobin 11-7 g/dl; white cell count 14 x 109/1 (14 000/mm3); platelets 96 
Comment
It seems likely that all intra-amniotic hypertonic solutions have a similar effect on the placenta and trophoblast, and these changes are probably responsible for the alteration in clotting. The use of hypertonic solutions such as urea has two advantages. Firstly, the mean induction-abortion time is shorter than with oxytocin or prostaglandin used alone, and, secondly, urea in particular almost invariably kills the fetus, which avoids emotional confusion on the part of the patient and nurses at the abortion.
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Effect of cimetidine on lower oesophageal sphincter Erosive oesophagitis is a major complication of fulminant hepatic failure (FHF). In a previous study' the incidence of bleeding was decreased by the prophylactic administration of the H2-receptor antagonists metiamide and cimetidine intravenously. This was attributed to a reduced acidity of gastric contents, which may reflux in recumbency and in the presence of a nasogastric tube. Another possibility, however, is that the treatment increased the lower oesophageal sphincter pressure (LOSP), as occurs in opossums given metiamide.2 We have examined whether such an effect does, in fact, occur in man.
Methods and results
Oesophageal manometry was performed on six normal volunteers (four men and two women) with an average age of 28 years after an overnight fast. A single-lumen (internal diameter 1-5 mm, outer diameter 6 mm), continuously perfused (4-4 mllmin) catheter was used with three recording orifices at the same level 120°apart. 
Comment
In the opossum study2 metiamide increased the LOSP when infused at 2 mg/kg/hour, but at higher infusion rates a decrease in pressure occurred. Only one of our six volunteers showed an increase in LOSP with low blood cimetidine levels and a fall as the blood cimetidine concentration increased. Perhaps there was some positive influence on the LOSP occurring at 15 minutes in the remaining five volunteers, as the early and unexplained drop in pressures measured during the control studies appeared to have been attenuated.
Thus cimetidine may have a biomodal effect on LOSP in man, with stimulation of the sphincter at low blood levels and slight inhibition at high blood levels, accounting for an early pressure rise and a decrease 30 minutes later. The failure of cimetidine to cause a sustained increase in LOSP, however, suggests that it prevents bleeding erosive oesophagitis in FHF by decreasing gastric acidity.
